Gangwon-do, Demonstration of AI Solution for Predicting Prostate Cancer Onset

Development of AI for Prostate Cancer Risk Management
Enabling Follow-up and Monitoring of Patients

Gangwon Province will undertake the demonstration project of the "Prostate Cancer Prediction Artificial Intelligence Solution Development," which is a demonstration project of the "Gangwon Precision Medical Industry Regulatory Free Zone" designated by the Ministry of SMEs and Startups.

Gangwon Provincial Government

According to the province on the 1st, the "Prostate Cancer Prediction Artificial Intelligence Solution Development" aims to develop an AI solution that manages the risk of prostate cancer occurrence and enables tracking and monitoring of patients by utilizing demonstration exemption data from Gangwon Province.

Last December, the province began developing precision medical AI solutions for three diseases: chronic liver disease, brain injury, and facial bone fractures, and plans to complete four demonstration projects by November.

The development of the prostate cancer prediction AI solution is a joint effort by Life Semantics Co., Gangwon National University Hospital, and Wonju Severance Christian Hospital.

Previously, in 2021, an area of 183,112㎡ around Chuncheon and Wonju in Gangwon was designated as a precision medical regulatory free zone. This is the third regulatory free zone in Gangwon Province, following digital healthcare (Wonju and Chuncheon) and liquefied hydrogen (Gangneung, Donghae, Samcheok, and Pyeongchang).

Yoon In-jae, Director of the Industry Bureau of Gangwon Province, said, "We will do our best to successfully promote the Gangwon Province precision medical AI development demonstration project to foster a big data-based precision medical industry within the province and attract related companies."

This content was produced with the assistance of AI translation services.